Name: | Procaterol |
---|---|
PubChem Compound ID: | 43091 |
Description: | A long-acting beta-2-adrenergic receptor agonist. |
Molecular formula: | C16H23ClN2O3 |
Molecular weight: | 326.818 g/mol |
Synonyms: |
2(1H)-Quinolinone, 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-, monohydrochloride, (R*,S*), (+-)-; Pro-Air; 62929-91-3; Meptin; (+-)-erythro-8-Hydroxy-5-(1-hydroxy-2-(isopropylamino)butyl)carbostyril monohydrochloride; 59828-07-8; 60443-17-6; 5-(1-Hydroxy-2-isopropylamino)butyl-8-hydroxycarbostyril hydrochloride; 2(1H)-Quinolinone, 8-hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-, monohydrochloride, (R*,S*)-(+-)-; (R*,S*)-(1)-8-Hydroxy-5-(1-hydroxy-2-(isopropylamino)butyl)quinolin-2(1H)-one monohydrochloride.
show more » |
Name: | Procaterol |
---|---|
Name (isomeric): | DB01366 |
Drug Type: | small molecule |
Description: | A long-acting beta-2-adrenergic receptor agonist. |
Brand: | Pro-Air |
Category: | Adrenergic beta-Agonists, Sympathomimetics, Bronchodilator Agents |
CAS number: | 72332-33-3 |
Indication: | For the treatment of asthma and chronic obstructive pulmonary disease (COPD). |
---|---|
Pharmacology: | Procaterol is a long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. |
Mechanism of Action: | Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow. |
Absorption: | Because of the small therapeutic dose, systemic levels of salmeterol are low or undetectable after inhalation of recommended doses. |
Toxicity: | Symptoms of overdose include angina (chest pain), dizziness, dry mouth, fatigue, flu-like symptoms, headache, heart irregularities, high or low blood pressure, high blood sugar, insomnia, muscle cramps, nausea, nervousness, rapid heartbeat, seizures, and tremor. |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|